Nuveen, LLC Enochian Biosciences Inc Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Nuveen, LLC holds 151,681 shares of ENOB stock, worth $697,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
151,681Holding current value
$697,732% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ENOB
# of Institutions
61Shares Held
18.6MCall Options Held
41.4KPut Options Held
49.2K-
Vanguard Group Inc Valley Forge, PA5.66MShares$26 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.37MShares$10.9 Million0.0% of portfolio
-
State Street Corp Boston, MA2.06MShares$9.5 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL889KShares$4.09 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...